Europe races to shield virus-hit firms from bargain hunters

Fears that cash-rich corporate raiders could use the coronavirus crisis to swoop on weakened European firms were perhaps best exemplified by Donald Trump’s alleged bid for a German biotech firm working on a vaccine.